← Leaderboards
Paolo Fanti
University Of Kentucky
$1,158,978
Attributed
$1,158,978
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $187.1K · FY2006–14$200K$150K$100K$50K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$1,158,978 · 6
VA$0 · 1
By mechanism
R21$1,076,100 · 3
M01$82,878 · 3
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Kentucky
Same institution · by research overlap
- Kathryn M Thrailkill$1,641,998
- Zhuo Zhang$5,665,815
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchDiabetic NephropathyCytokineInflammationKidneyBloodClinical TrialsKidney DiseasesDiabeticAntioxidantsIntakePreventUrineAcetylcysteineDialysis ProcedureBeta-ChemokinesConventional TherapyDesignDietary InterventionActive MethodAnimal ModelComplementAlbuminsAdverse Effects
Grant awards (14)
Correction of glutathione deficiency for treatment of diabetic nephropathy$0
I01 · FY2014 · VA · contact PI
Correction of glutathione deficiency for treatment of diabetic nephropathy$0
I01 · FY2013 · VA · contact PI
Correction of glutathione deficiency for treatment of diabetic nephropathy$0
I01 · FY2012 · VA · contact PI
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy$154,365
R21 · FY2011 · AT · contact PI
Correction of glutathione deficiency for treatment of diabetic nephropathy$0
I01 · FY2011 · VA · contact PI
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy$187,110
R21 · FY2010 · AT · contact PI
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy$157,500
R21 · FY2009 · AT · contact PI
PK OF SILYBIN-PHOSPHATIDYLCHOLINE COMPLEX (SILIPHOS) IN DIABETIC NEPHROPATHY$45,716
M01 · FY2007 · RR · contact PI
PK OF SILYBIN-PHOSPHATIDYLCHOLINE COMPLEX (SILIPHOS) IN DIABETIC NEPHROPATHY$10,704
M01 · FY2006 · RR · contact PI
Isoflavones:Acute Response in Chronic Renal Failure$144,800
R21 · FY2002 · AT
Isoflavones:Acute Response in Chronic Renal Failure$144,800
R21 · FY2001 · AT
SOY PROTEIN USE IN EARLY DIABETIC NEPHROPATHY$144,430
R21 · FY2001 · AT
SOY PROTEIN USE IN EARLY DIABETIC NEPHROPATHY$143,095
R21 · FY2000 · AT
SOYBEAN &URINE LITHOGENICITY IN RECURRENT CALCIUM OXALATE NEPHROPATHY$26,458
M01 · FY2000 · RR